Research & Development



  就在隋越快要被自己的汗水淹死的時候,就听皇帝清朗的聲音響起。   雲瑯吐掉嘴里的血,艱難的道︰“我沒暈過去。”伊人影院   甦建說完話,又別有深意的看了雲瑯一眼。超碰在线   霍光驕傲的點點頭道︰“你才知道嗎?我八歲的時候就知道我老婆是誰了,一般人沒這本事。”   說實在的,如果沒有後世的那些學問支撐,雲瑯覺得自己不是大漢朝那些精英們的對手。超碰免费公开视频   而第一次考試,一定是不完善的,也是不安全的,更是爭斗的最激烈的一次考試。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo